Ronak Darou Company
Ronak Pharmaceutical Company is a private, knowledge-based Iranian pharmaceutical manufacturer headquartered in Tehran, with manufacturing in Saveh. It develops, manufactures and markets specialty medicines, injectables and advanced generics across neurology, diabetes, anticoagulation, urology and pain management. Its portfolio and R&;D-led operating model make it relevant to pharmaceutical buyers, distributors, suppliers and manufacturing partners.
Operations & footprint
Products and services
Ronak Darou Company develops, manufactures, markets, and supports specialized pharmaceutical products, including botulinum toxin type A, neurology medicines, epilepsy treatments, anticoagulants, diabetes medicines, insulin products, corticosteroids, pain and inflammation products, urology products, and selected injectable or advanced generic medicines. Its operations include R&;D, patient-support activity, Tehran-based commercial operations, and a manufacturing base in Saveh.
Operations and assets
The company’s operating footprint combines Tehran-based commercial operations, R&;D and patient-support activities with a manufacturing base in Saveh, Markazi Province.
Geographic footprint
Head office and commercial operations are based in Tehran, Tehran Province. Manufacturing is based in Saveh, Markazi Province, Iran.
Commercial and investment relevance
Ronak Darou is relevant for investors assessing Iran's specialized pharmaceutical market, neurology and diabetes demand, advanced generics, botulinum-toxin localization, insulin access, and high-value medicine substitution under import constraints. It can support analysis of R&;D capability, regulatory barriers, technology transfer, product differentiation, patient-support infrastructure, and export potential. Due diligence should verify ownership, manufacturing licenses, GMP status, product registrations, active production lines, API and biologic input sourcing, technology partners, export registrations, pharmacovigilance systems, intellectual-property exposure, and sanctions or payment-channel constraints. The company is relevant to distributors, healthcare partners and suppliers seeking access to specialty medicines, insulin and diabetes therapies, neurology products, botulinum toxin type A, injectables and advanced generic formulations in Iran.
Need more than a public profile?
Ask Hormuz to investigate, verify or act locally around Ronak Darou Company. Tell us exactly what you need.
Connected Intelligence
Relevant geography, industry, market and execution context for this profile.
Frequently asked questions
Direct answers to the questions most likely to arise when reviewing this profile.
What does Ronak Pharmaceutical Company manufacture?
Ronak Pharmaceutical Company develops and manufactures specialty medicines, injectables and advanced generics, including botulinum toxin type A, insulin and diabetes therapies, neurology and epilepsy treatments, anticoagulants, corticosteroids, urology products and pain-management medicines.
Where does Ronak Pharmaceutical Company operate?
The company is headquartered in Tehran, Iran, with commercial operations, R&;D and patient-support activities linked to Tehran. Its manufacturing base is in Saveh, Markazi Province.
Is Ronak Pharmaceutical Company publicly listed?
Ronak Pharmaceutical Company is a private company.